Glickman Urological & Kidney Institute Outcomes
Surgical Quality Improvement
Transurethral Resection of the Prostate (TURP) Outcomes
January 1, 2020 – December 31, 2020
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s transurethral resection of the prostate (TURP) ACS NSQIP performance benchmarked against 435 participating sites.
|Transurethral Resection of the Prostate (TURP) (435 sites)||N||Observed||Expected|
|30 Day Morbidity||67||5.97%||4.33%|
|Urinary Tract Infection (UTI)||67||2.99%||3.31%|
|Return to Operating Room (ROR)||67||0.00%||1.40%|
American College of Surgeons National Surgical Quality Improvement Program, 2021.
ACS NSQIP® Semiannual Report July 8, 2021, Chicago: American College of Surgeons.